Kapitalo Investimentos’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-523
Closed -$272K 302
2024
Q3
$272K Sell
523
-38
-7% -$20.3K 0.07% 111
2024
Q2
$304K Sell
561
-354
-39% -$187K 0.09% 85
2024
Q1
$474K Sell
915
-378
-29% -$188K 0.1% 93
2023
Q4
$610K Buy
1,293
+374
+41% +$173K 0.13% 75
2023
Q3
$400K Buy
919
+675
+277% +$306K 0.05% 144
2023
Q2
$108K Buy
+244
New +$113K 0.02% 339

Other funds holding ELV

Kapitalo Investimentos's ELV Position: Q4 2024 in Review

Kapitalo Investimentos sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 523 shares — an estimated $272K sold.

Kapitalo Investimentos first reported a position in ELV in Q2 2023 and held it in 6 quarters. The position peaked at $610K in Q4 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Kapitalo Investimentos reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Kapitalo Investimentos sold 523 Elevance Health shares in Q4 2024, an estimated $272K.
  • Kapitalo Investimentos first reported a position in Elevance Health in Q2 2023 and held it in 6 quarters.
  • Kapitalo Investimentos's Elevance Health position peaked at $610K in Q4 2023.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Kapitalo Investimentos's 13F filing for Q4 2024, filed 14 Feb 2025.